Global CIS Insulin Market Research Report 2023

Report ID: 1992020 | Published Date: Sep 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CIS Insulin Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Long-Acting Analog
        1.2.3 Rapid Acting Analog
        1.2.4 Premixed Analog
        1.2.5 Intermediate Insulin
        1.2.6 Short Acting Insulin
        1.2.7 Premixed Insulin
    1.3 Market by Application
        1.3.1 Global CIS Insulin Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Type I and Other Diabetes
        1.3.3 Type II Diabetes
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global CIS Insulin Market Perspective (2018-2029)
    2.2 CIS Insulin Growth Trends by Region
        2.2.1 Global CIS Insulin Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 CIS Insulin Historic Market Size by Region (2018-2023)
        2.2.3 CIS Insulin Forecasted Market Size by Region (2024-2029)
    2.3 CIS Insulin Market Dynamics
        2.3.1 CIS Insulin Industry Trends
        2.3.2 CIS Insulin Market Drivers
        2.3.3 CIS Insulin Market Challenges
        2.3.4 CIS Insulin Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CIS Insulin Players by Revenue
        3.1.1 Global Top CIS Insulin Players by Revenue (2018-2023)
        3.1.2 Global CIS Insulin Revenue Market Share by Players (2018-2023)
    3.2 Global CIS Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CIS Insulin Revenue
    3.4 Global CIS Insulin Market Concentration Ratio
        3.4.1 Global CIS Insulin Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CIS Insulin Revenue in 2022
    3.5 CIS Insulin Key Players Head office and Area Served
    3.6 Key Players CIS Insulin Product Solution and Service
    3.7 Date of Enter into CIS Insulin Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CIS Insulin Breakdown Data by Type
    4.1 Global CIS Insulin Historic Market Size by Type (2018-2023)
    4.2 Global CIS Insulin Forecasted Market Size by Type (2024-2029)
5 CIS Insulin Breakdown Data by Application
    5.1 Global CIS Insulin Historic Market Size by Application (2018-2023)
    5.2 Global CIS Insulin Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America CIS Insulin Market Size (2018-2029)
    6.2 North America CIS Insulin Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America CIS Insulin Market Size by Country (2018-2023)
    6.4 North America CIS Insulin Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe CIS Insulin Market Size (2018-2029)
    7.2 Europe CIS Insulin Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe CIS Insulin Market Size by Country (2018-2023)
    7.4 Europe CIS Insulin Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CIS Insulin Market Size (2018-2029)
    8.2 Asia-Pacific CIS Insulin Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific CIS Insulin Market Size by Region (2018-2023)
    8.4 Asia-Pacific CIS Insulin Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America CIS Insulin Market Size (2018-2029)
    9.2 Latin America CIS Insulin Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America CIS Insulin Market Size by Country (2018-2023)
    9.4 Latin America CIS Insulin Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CIS Insulin Market Size (2018-2029)
    10.2 Middle East & Africa CIS Insulin Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa CIS Insulin Market Size by Country (2018-2023)
    10.4 Middle East & Africa CIS Insulin Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Detail
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly CIS Insulin Introduction
        11.1.4 Eli Lilly Revenue in CIS Insulin Business (2018-2023)
        11.1.5 Eli Lilly Recent Development
    11.2 Novo Nordisk
        11.2.1 Novo Nordisk Company Detail
        11.2.2 Novo Nordisk Business Overview
        11.2.3 Novo Nordisk CIS Insulin Introduction
        11.2.4 Novo Nordisk Revenue in CIS Insulin Business (2018-2023)
        11.2.5 Novo Nordisk Recent Development
    11.3 Takeda Pharmaceuticals
        11.3.1 Takeda Pharmaceuticals Company Detail
        11.3.2 Takeda Pharmaceuticals Business Overview
        11.3.3 Takeda Pharmaceuticals CIS Insulin Introduction
        11.3.4 Takeda Pharmaceuticals Revenue in CIS Insulin Business (2018-2023)
        11.3.5 Takeda Pharmaceuticals Recent Development
    11.4 Sanofi Aventis
        11.4.1 Sanofi Aventis Company Detail
        11.4.2 Sanofi Aventis Business Overview
        11.4.3 Sanofi Aventis CIS Insulin Introduction
        11.4.4 Sanofi Aventis Revenue in CIS Insulin Business (2018-2023)
        11.4.5 Sanofi Aventis Recent Development
    11.5 Nanjing Xinbai Pharmaceutical
        11.5.1 Nanjing Xinbai Pharmaceutical Company Detail
        11.5.2 Nanjing Xinbai Pharmaceutical Business Overview
        11.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Introduction
        11.5.4 Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2018-2023)
        11.5.5 Nanjing Xinbai Pharmaceutical Recent Development
    11.6 Oramed Pharmaceuticals
        11.6.1 Oramed Pharmaceuticals Company Detail
        11.6.2 Oramed Pharmaceuticals Business Overview
        11.6.3 Oramed Pharmaceuticals CIS Insulin Introduction
        11.6.4 Oramed Pharmaceuticals Revenue in CIS Insulin Business (2018-2023)
        11.6.5 Oramed Pharmaceuticals Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck CIS Insulin Introduction
        11.7.4 Merck Revenue in CIS Insulin Business (2018-2023)
        11.7.5 Merck Recent Development
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Detail
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim CIS Insulin Introduction
        11.8.4 Boehringer Ingelheim Revenue in CIS Insulin Business (2018-2023)
        11.8.5 Boehringer Ingelheim Recent Development
    11.9 Biocon
        11.9.1 Biocon Company Detail
        11.9.2 Biocon Business Overview
        11.9.3 Biocon CIS Insulin Introduction
        11.9.4 Biocon Revenue in CIS Insulin Business (2018-2023)
        11.9.5 Biocon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global CIS Insulin Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Long-Acting Analog
    Table 3. Key Players of Rapid Acting Analog
    Table 4. Key Players of Premixed Analog
    Table 5. Key Players of Intermediate Insulin
    Table 6. Key Players of Short Acting Insulin
    Table 7. Key Players of Premixed Insulin
    Table 8. Global CIS Insulin Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global CIS Insulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global CIS Insulin Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global CIS Insulin Market Share by Region (2018-2023)
    Table 12. Global CIS Insulin Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global CIS Insulin Market Share by Region (2024-2029)
    Table 14. CIS Insulin Market Trends
    Table 15. CIS Insulin Market Drivers
    Table 16. CIS Insulin Market Challenges
    Table 17. CIS Insulin Market Restraints
    Table 18. Global CIS Insulin Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global CIS Insulin Market Share by Players (2018-2023)
    Table 20. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CIS Insulin as of 2022)
    Table 21. Ranking of Global Top CIS Insulin Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by CIS Insulin Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players CIS Insulin Product Solution and Service
    Table 25. Date of Enter into CIS Insulin Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global CIS Insulin Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global CIS Insulin Revenue Market Share by Type (2018-2023)
    Table 29. Global CIS Insulin Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global CIS Insulin Revenue Market Share by Type (2024-2029)
    Table 31. Global CIS Insulin Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global CIS Insulin Revenue Market Share by Application (2018-2023)
    Table 33. Global CIS Insulin Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global CIS Insulin Revenue Market Share by Application (2024-2029)
    Table 35. North America CIS Insulin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America CIS Insulin Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America CIS Insulin Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe CIS Insulin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe CIS Insulin Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe CIS Insulin Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific CIS Insulin Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific CIS Insulin Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific CIS Insulin Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America CIS Insulin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America CIS Insulin Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America CIS Insulin Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa CIS Insulin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa CIS Insulin Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa CIS Insulin Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Eli Lilly Company Detail
    Table 51. Eli Lilly Business Overview
    Table 52. Eli Lilly CIS Insulin Product
    Table 53. Eli Lilly Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 54. Eli Lilly Recent Development
    Table 55. Novo Nordisk Company Detail
    Table 56. Novo Nordisk Business Overview
    Table 57. Novo Nordisk CIS Insulin Product
    Table 58. Novo Nordisk Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 59. Novo Nordisk Recent Development
    Table 60. Takeda Pharmaceuticals Company Detail
    Table 61. Takeda Pharmaceuticals Business Overview
    Table 62. Takeda Pharmaceuticals CIS Insulin Product
    Table 63. Takeda Pharmaceuticals Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 64. Takeda Pharmaceuticals Recent Development
    Table 65. Sanofi Aventis Company Detail
    Table 66. Sanofi Aventis Business Overview
    Table 67. Sanofi Aventis CIS Insulin Product
    Table 68. Sanofi Aventis Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 69. Sanofi Aventis Recent Development
    Table 70. Nanjing Xinbai Pharmaceutical Company Detail
    Table 71. Nanjing Xinbai Pharmaceutical Business Overview
    Table 72. Nanjing Xinbai Pharmaceutical CIS Insulin Product
    Table 73. Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 74. Nanjing Xinbai Pharmaceutical Recent Development
    Table 75. Oramed Pharmaceuticals Company Detail
    Table 76. Oramed Pharmaceuticals Business Overview
    Table 77. Oramed Pharmaceuticals CIS Insulin Product
    Table 78. Oramed Pharmaceuticals Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 79. Oramed Pharmaceuticals Recent Development
    Table 80. Merck Company Detail
    Table 81. Merck Business Overview
    Table 82. Merck CIS Insulin Product
    Table 83. Merck Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 84. Merck Recent Development
    Table 85. Boehringer Ingelheim Company Detail
    Table 86. Boehringer Ingelheim Business Overview
    Table 87. Boehringer Ingelheim CIS Insulin Product
    Table 88. Boehringer Ingelheim Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 89. Boehringer Ingelheim Recent Development
    Table 90. Biocon Company Detail
    Table 91. Biocon Business Overview
    Table 92. Biocon CIS Insulin Product
    Table 93. Biocon Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
    Table 94. Biocon Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CIS Insulin Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global CIS Insulin Market Share by Type: 2022 VS 2029
    Figure 3. Long-Acting Analog Features
    Figure 4. Rapid Acting Analog Features
    Figure 5. Premixed Analog Features
    Figure 6. Intermediate Insulin Features
    Figure 7. Short Acting Insulin Features
    Figure 8. Premixed Insulin Features
    Figure 9. Global CIS Insulin Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global CIS Insulin Market Share by Application: 2022 VS 2029
    Figure 11. Type I and Other Diabetes Case Studies
    Figure 12. Type II Diabetes Case Studies
    Figure 13. CIS Insulin Report Years Considered
    Figure 14. Global CIS Insulin Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global CIS Insulin Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global CIS Insulin Market Share by Region: 2022 VS 2029
    Figure 17. Global CIS Insulin Market Share by Players in 2022
    Figure 18. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CIS Insulin as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by CIS Insulin Revenue in 2022
    Figure 20. North America CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America CIS Insulin Market Share by Country (2018-2029)
    Figure 22. United States CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe CIS Insulin Market Share by Country (2018-2029)
    Figure 26. Germany CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific CIS Insulin Market Share by Region (2018-2029)
    Figure 34. China CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America CIS Insulin Market Share by Country (2018-2029)
    Figure 42. Mexico CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa CIS Insulin Market Share by Country (2018-2029)
    Figure 46. Turkey CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia CIS Insulin Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Eli Lilly Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 49. Novo Nordisk Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 50. Takeda Pharmaceuticals Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 51. Sanofi Aventis Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 52. Nanjing Xinbai Pharmaceutical Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 53. Oramed Pharmaceuticals Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 54. Merck Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 55. Boehringer Ingelheim Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 56. Biocon Revenue Growth Rate in CIS Insulin Business (2018-2023)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Novo Nordisk
Takeda Pharmaceuticals
Sanofi Aventis
Nanjing Xinbai Pharmaceutical
Oramed Pharmaceuticals
Merck
Boehringer Ingelheim
Biocon
Frequently Asked Questions
CIS Insulin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CIS Insulin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CIS Insulin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Civil Engineering

This report aims to provide a comprehensive presentation of the global market for Civil Engineeri ... Read More

Cladding

This report aims to provide a comprehensive presentation of the global market for Cladding, with  ... Read More